bioMérieux (Paris:BIM), a major player in the field of in vitro diagnostics, and the world leader in microbiology, announces that BacT/ALERT VIRTUO™, its fully automated blood culture system, has ...
French life sciences company bioMérieux – which recently hosted a ribbon cutting for its $60 million Durham facility expansion– has received U.S. Food and Drug Administration clearance for a new ...
MARCY L'ETOILE, France--(BUSINESS WIRE)--Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today released its business review for the nine months ended ...
Sepsis is one of the most significant challenges in critical care, and early diagnosis is a decisive factor in determining patient outcomes. Sepsis is a medical emergency, and it is the leading cause ...
A blood culture is a routine laboratory test in which blood – or another sterile body fluid – is taken from a patient and inoculated into bottles containing specialized media to determine whether ...
bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and ...
bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and ...
* Biomerieux receives FDA 510(k) clearance for its BacT/ALERT VIRTUO fully automated blood culture system Source text for Eikon: Further company coverage: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback